{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:51:03Z","timestamp":1782924663102,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00103-026-04255-1","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:14:49Z","timestamp":1782216889000},"page":"744-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Juristische und gesellschaftliche Aspekte von Doping im Sport","Legal and societal aspects of doping in sport"],"prefix":"10.1007","volume":"69","author":[{"given":"Heiko","family":"Striegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"1","key":"4255_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40545-021-00350-7","volume":"14","author":"M Algarni","year":"2021","unstructured":"Algarni\u00a0M, Hadi\u00a0MA, Yahyouche\u00a0A, Mahmood\u00a0S, Jalal\u00a0Z (2021) A mixed-methods systematic review of the prevalence, reasons, associated harms and risk-reduction interventions of over-the-counter (OTC) medicines misuse, abuse and dependence in adults. J\u00a0Pharm Policy Pract 14(1):76\u201376. https:\/\/doi.org\/10.1186\/s40545-021-00350-7","journal-title":"J Pharm Policy Pract"},{"issue":"1-3","key":"4255_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.forsciint.2011.07.026","volume":"213","author":"M Kamber","year":"2011","unstructured":"Kamber\u00a0M (2011) Development of the role of national anti-doping organisations in the fight against doping: from past to future. Forensic Sci Int 213(1-3):3\u20139. https:\/\/doi.org\/10.1016\/j.forsciint.2011.07.026","journal-title":"Forensic Sci Int"},{"key":"4255_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000460681","volume":"62","author":"R Young","year":"2017","unstructured":"Young\u00a0R (2017) The Development of the World Anti-Doping Code. Med Sport Sci 62:11\u201321. https:\/\/doi.org\/10.1159\/000460681","journal-title":"Med Sport Sci"},{"key":"4255_CR4","unstructured":"Nationale Anti-Doping Agentur (NADA) (2005) Doping-Bilanz der NADA f\u00fcr den Deutschen Sport 2004. https:\/\/www.nada.de\/fileadmin\/nada\/SERVICE\/Downloads\/Jahresberichte\/2004_NADA_Jahresbericht.pdf. Zugegriffen: 17. Febr. 2026"},{"key":"4255_CR5","unstructured":"World Anti-Doping Agency (WADA). World Anti-Doping Code. https:\/\/www.wada-ama.org\/en\/what-we-do\/world-anti-doping-code. Zugegriffen: 17. Febr. 2026"},{"key":"4255_CR6","unstructured":"Nationale Anti-Doping Agentur (NADA). Nationaler Anti-Doping Code. https:\/\/www.nada.de\/fileadmin\/nada\/SERVICE\/Downloads\/Regelwerke\/2021_Nationaler_Anti-Doping_Code_2021.pdf. Zugegriffen: 17. Febr. 2026"},{"key":"4255_CR7","unstructured":"World Anti-Doping Agency (WADA) (2024) Anti-Doping Testing Figures. https:\/\/www.wada-ama.org\/sites\/default\/files\/2025-12\/2024_Anti-Doping%20Testing%20Figures%20Report_FINAL_v3.pdf. Zugegriffen: 17. Febr. 2026"},{"issue":"7","key":"4255_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/bjsports-2017-098299","volume":"52","author":"P Borry","year":"2018","unstructured":"Borry\u00a0P, Caulfield\u00a0T, Estivill\u00a0X, Loland\u00a0S, McNamee\u00a0M, Knoppers\u00a0BM, WADA Ethics Panel (2018) Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel. Br J Sports Med 52(7):456\u2013459. https:\/\/doi.org\/10.1136\/bjsports-2017-098299","journal-title":"Br J Sports Med"},{"key":"4255_CR9","unstructured":"Heger M (2001) Die Strafbarkeit von Doping nach dem Arzneimittelgesetz. SpuRt S.\u00a092\u201395."},{"key":"4255_CR10","unstructured":"Bundesministerium f\u00fcr Justiz. Gesetz gegen Doping im Sport (Anti-Doping-Gesetz - AntiDopG). https:\/\/www.gesetze-im-internet.de\/antidopg\/BJNR221010015.html. Zugegriffen: 17. Febr. 2026"},{"key":"4255_CR11","isbn-type":"print","volume-title":"AntiDopG. Anti-Doping Gesetz. Kommentar","year":"2024","unstructured":"Lehner\u00a0M, Nolete\u00a0M, Putzke\u00a0H (Hrsg) (2024) AntiDopG. Anti-Doping Gesetz. Kommentar, 2.\u00a0Aufl. Nomos Verlag. ISBN 978-3-8487-7317\u20116.","ISBN":"https:\/\/id.crossref.org\/isbn\/9783848773176","edition":"2"},{"issue":"5","key":"4255_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/medethics-2015-103091","volume":"43","author":"C Breitsameter","year":"2017","unstructured":"Breitsameter\u00a0C (2017) How to justify a ban on doping? Med Humanit 43(5):287\u2013292. https:\/\/doi.org\/10.1136\/medethics-2015-103091","journal-title":"J Med Ethics"},{"issue":"10","key":"4255_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/bjsports-2014-093654","volume":"48","author":"A Ljungqvist","year":"2014","unstructured":"Ljungqvist\u00a0A (2014) The fight against doping is a fight for the protection of the clean athlete, the health of the athlete and the integrity of sport. Br J Sports Med 48(10):799. https:\/\/doi.org\/10.1136\/bjsports-2014-093654","journal-title":"Br J Sports Med"},{"issue":"3","key":"4255_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/bjp.2008.165","volume":"154","author":"AT Kicman","year":"2008","unstructured":"Kicman\u00a0AT (2008) Pharmacology of anabolic steroids. Br J Pharmacol 154(3):502\u2013521. https:\/\/doi.org\/10.1038\/bjp.2008.165","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4255_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/13813455.2025.2459283","volume":"131","author":"H Alizadeh Pahlavani","year":"2025","unstructured":"Alizadeh Pahlavani\u00a0H, Veisi\u00a0A (2025) Possible consequences of the abuse of anabolic steroids on different organs of athletes. Arch Physiol Biochem 131(3):393\u2013409. https:\/\/doi.org\/10.1080\/13813455.2025.2459283","journal-title":"Arch Physiol Biochem"},{"issue":"1 Suppl","key":"4255_CR16","first-page":"7","volume":"21","author":"R Solimini","year":"2017","unstructured":"Solimini\u00a0R, Rotolo\u00a0MC, Mastrobattista\u00a0L, Mortali\u00a0C, Minutillo\u00a0A, Pichini\u00a0S, Pacifici\u00a0R, Palmi\u00a0I (2017) Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping. Eur Rev Med Pharmacol Sci 21(1 Suppl):7\u201316","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"4255_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0049-3848(95)91520-u","volume":"79","author":"N Clyne","year":"1995","unstructured":"Clyne\u00a0N, Berglund\u00a0B, Egberg\u00a0N (1995) Treatment with recombinant human erythropoietin induces a\u00a0moderate rise in hematocrit and thrombin antithrombin in healthy subjects. Thromb Res 79(1):125\u2013129. https:\/\/doi.org\/10.1016\/0049-3848(95)91520-u","journal-title":"Thromb Res"},{"issue":"6","key":"4255_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.7416\/ai.2019.2319","volume":"31","author":"M De Santi","year":"2019","unstructured":"De Santi\u00a0M, Baldelli\u00a0G, Brandi\u00a0G, GSMS-SItI, Working Group on Movement Sciences for Health, Italian Society of Hygiene preventive Medicine and Public Health, WDPP, Working Group Doping Prevention Project (2019) Use of hormones in doping and cancer risk. Ann Ig 31(6):590\u2013594. https:\/\/doi.org\/10.7416\/ai.2019.2319","journal-title":"Ann Ig"},{"issue":"2","key":"4255_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1559827616680593","volume":"11","author":"ND White","year":"2016","unstructured":"White\u00a0ND, Noeun\u00a0J (2016) Performance-Enhancing Drug Use in Adolescence. Am J Lifestyle Med 11(2):122\u2013124. https:\/\/doi.org\/10.1177\/1559827616680593","journal-title":"Am J Lifestyle Med"},{"issue":"12","key":"4255_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/sports12120348","volume":"12","author":"V Focaroli","year":"2024","unstructured":"Focaroli\u00a0V, Chiaro\u00a0M, Battaglia\u00a0MV, Guidetti\u00a0L, Velardi\u00a0A (2024) Educational Intervention on Awareness of Health-Damaging Behaviors in Educators. Sports 12(12):348. https:\/\/doi.org\/10.3390\/sports12120348","journal-title":"Sports (Basel)"},{"issue":"3","key":"4255_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jshs.2019.12.002","volume":"9","author":"K Gatterer","year":"2020","unstructured":"Gatterer\u00a0K, Gumpenberger\u00a0M, Overbye\u00a0M, Streicher\u00a0B, Schobersberger\u00a0W, Blank\u00a0C (2020) An evaluation of prevention initiatives by 53 national anti-doping organizations: Achievements and limitations. J\u00a0Sport Health Sci 9(3):228\u2013239. https:\/\/doi.org\/10.1016\/j.jshs.2019.12.002","journal-title":"J Sport Health Sci"},{"issue":"1","key":"4255_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugalcdep.2005.05.013","volume":"81","author":"H Striegel","year":"2006","unstructured":"Striegel\u00a0H, Simon\u00a0P, Frisch\u00a0S, Roecker\u00a0K, Dietz\u00a0K, Dickhuth\u00a0HH, Ulrich\u00a0R (2006) Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system. Drug Alcohol Depend 81(1):11\u201319. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.05.013","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"4255_CR23","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/j.1360-0443.2006.01568.x","volume":"101","author":"P S Simon","year":"2006","unstructured":"S Simon\u00a0P, Striegel\u00a0H, Aust\u00a0F, Dietz\u00a0K, Ulrich\u00a0R (2006) Doping in fitness sports: estimated number of unreported cases and individual probability of doping. Addiction 101(11):1640\u20131644. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01568.x","journal-title":"Addiction"},{"key":"4255_CR24","unstructured":"Nationale Anti-Doping Agentur (NADA). Gemeinsam gegen Doping. https:\/\/www.nada.de\/praevention\/gemeinsam-gegen-doping. Zugegriffen: 17. Febr. 2026"},{"key":"4255_CR25","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.18.0502","author":"C Helle","year":"2019","unstructured":"Helle\u00a0C, Sommer\u00a0AK, Syversen\u00a0PV, Lauritzen\u00a0F (2019) Doping substances in dietary supplements. Tidsskr Nor Laegeforen. https:\/\/doi.org\/10.4045\/tidsskr.18.0502","journal-title":"Tidsskr Nor Laegeforen"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04255-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-026-04255-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04255-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:05:42Z","timestamp":1782921942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-026-04255-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4255"],"URL":"https:\/\/doi.org\/10.1007\/s00103-026-04255-1","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Striegel gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}